Phase 2 Osteoarthritis Trial, Recruiting (NCT03552705)

Phase 2 Osteoarthritis Trial, Recruiting NCT03552705 Sponsor: Stanford University Condition: Osteoarthritis

Printed from Voxsanity (voxsanity.com.au) — NCT03552705 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoarthritis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged between 18 and 30 years old
People who have injured the ACL (a ligament in the knee) in one knee within the last 4 days
People who have swelling or blood in the injured knee joint

Who may not be able to join:

People who have inflammatory arthritis, significant arthritis visible on X-ray, gout, or pseudogout
People who have a whole-body illness or infection that requires medication
People who have other injuries to the same knee, apart from certain cartilage (meniscus) or inner ligament (MCL) tears that do not need surgery
People who have had surgery on either knee at any point in the past
People who have had a previous knee injury serious enough to need crutches
People with a history of blood clots in veins or arteries
People who are currently using combined hormonal contraception (such as the combined pill, patch, or ring)
People who regularly use anti-inflammatory pain medicines (such as ibuprofen or naproxen)
People who have had a cortisone injection into either knee in the past 3 months
People for whom ACL reconstruction surgery is not recommended, or who are unable to have the surgery within 3 months of the injury (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Constance Chu, MD, Stanford University

Phone: 650-721-7612

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03552705

Sponsor: Stanford University

Phase: Phase 2

Status: Recruiting

Condition: Osteoarthritis

Trial contact: 650-721-7612

More information: https://clinicaltrials.gov/study/NCT03552705

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged between 18 and 30 years old
People who have injured the ACL (a ligament in the knee) in one knee within the last 4 days
People who have swelling or blood in the injured knee joint

Who may not be able to join:

People who have inflammatory arthritis, significant arthritis visible on X-ray, gout, or pseudogout
People who have a whole-body illness or infection that requires medication
People who have other injuries to the same knee, apart from certain cartilage (meniscus) or inner ligament (MCL) tears that do not need surgery
People who have had surgery on either knee at any point in the past
People who have had a previous knee injury serious enough to need crutches
People with a history of blood clots in veins or arteries
People who are currently using combined hormonal contraception (such as the combined pill, patch, or ring)
People who regularly use anti-inflammatory pain medicines (such as ibuprofen or naproxen)
People who have had a cortisone injection into either knee in the past 3 months
People for whom ACL reconstruction surgery is not recommended, or who are unable to have the surgery within 3 months of the injury (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Stanford University

Registry

ClinicalTrials.gov

Start date

1 August 2019

Est. completion

14 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Synovial fluid IL-1; Patient-Reported Outcomes (PRO): Knee injury and Osteoarthritis Outcome Score (KOOS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov